P07293 (CAC1S_RABIT) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 119.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Voltage-dependent L-type calcium channel subunit alpha-1S Alternative name(s): Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle Voltage-gated calcium channel subunit alpha Cav1.1 | ||||
| Gene names |
| ||||
| Organism | Oryctolagus cuniculus (Rabbit) [Reference proteome] | ||||
| Taxonomic identifier | 9986 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Lagomorpha › Leporidae › Oryctolagus![]() |
Protein attributes
| Sequence length | 1873 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1S gives rise to L-type calcium currents. Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group. They are blocked by dihydropyridines (DHP), phenylalkylamines, benzothiazepines, and by omega-agatoxin-IIIA (omega-Aga-IIIA). They are however insensitive to omega-conotoxin-GVIA (omega-CTx-GVIA) and omega-agatoxin-IVA (omega-Aga-IVA). Calcium channels containing the alpha-1S subunit play an important role in excitation-contraction coupling in skeletal muscle. |
| Subunit structure | Multisubunit complex consisting of alpha-1, alpha-2, beta and delta subunits in a 1:1:1:1 ratio. The channel activity is directed by the pore-forming and voltage-sensitive alpha-1 subunit. In many cases, this subunit is sufficient to generate voltage-sensitive calcium channel activity. The auxiliary subunits beta and alpha-2/delta linked by a disulfide bridge regulate the channel activity. An additional gamma subunit is present only in skeletal muscle L-type channel. Interacts with DYSF and JSRP1 By similarity. Interacts with RYR1. Ref.3 Ref.9 |
| Subcellular location | |
| Tissue specificity | Skeletal muscle specific. |
| Domain | Each of the four internal repeats contains five hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one positively charged transmembrane segment (S4). S4 segments probably represent the voltage-sensor and are characterized by a series of positively charged amino acids at every third position. Ref.3 The loop between repeats II and III interacts with the ryanodine receptor, and is therefore important for calcium release from the endoplasmic reticulum necessary for muscle contraction. Ref.3 |
| Post-translational modification | The alpha-1S subunit is found in two isoforms in the skeletal muscle: a minor form of 212 kDa containing the complete amino acid sequence, and a major form of 190 kDa derived from the full-length form by post-translational proteolysis close to Phe-1690. Both the minor and major forms are phosphorylated in vitro by PKA. Phosphorylation by PKA activates the calcium channel. Ref.7 Ref.8 |
| Sequence similarities | Belongs to the calcium channel alpha-1 subunit (TC 1.A.1.11) family. CACNA1S subfamily. [View classification] |
Ontologies
| Keywords | |
|---|---|
| Biological process | Calcium transport Ion transport Transport |
| Cellular component | Membrane |
| Coding sequence diversity | Polymorphism |
| Domain | Repeat Transmembrane Transmembrane helix |
| Ligand | Calcium Metal-binding |
| Molecular function | Calcium channel Ion channel Voltage-gated channel |
| PTM | Disulfide bond Glycoprotein Phosphoprotein |
| Technical term | 3D-structure Complete proteome Direct protein sequencing Reference proteome |
| Gene Ontology (GO) | |
| Cellular_component | voltage-gated calcium channel complex Inferred from electronic annotation. Source: InterPro |
| Molecular_function | metal ion binding Inferred from electronic annotation. Source: UniProtKB-KW voltage-gated calcium channel activityInferred from electronic annotation. Source: InterPro |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||
Molecule processing | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1873 | 1873 | Voltage-dependent L-type calcium channel subunit alpha-1S | PRO_0000053945 | ||||||||||
Regions | ||||||||||||||
| Topological domain | 1 – 51 | 51 | Cytoplasmic Potential | |||||||||||
| Transmembrane | 52 – 70 | 19 | Helical; Name=S1 of repeat I; Potential | |||||||||||
| Topological domain | 71 – 88 | 18 | Extracellular Potential | |||||||||||
| Transmembrane | 89 – 108 | 20 | Helical; Name=S2 of repeat I; Potential | |||||||||||
| Topological domain | 109 – 120 | 12 | Cytoplasmic Potential | |||||||||||
| Transmembrane | 121 – 139 | 19 | Helical; Name=S3 of repeat I; Potential | |||||||||||
| Topological domain | 140 – 160 | 21 | Extracellular Potential | |||||||||||
| Transmembrane | 161 – 179 | 19 | Helical; Name=S4 of repeat I; Potential | |||||||||||
| Topological domain | 180 – 198 | 19 | Cytoplasmic Potential | |||||||||||
| Transmembrane | 199 – 218 | 20 | Helical; Name=S5 of repeat I; Potential | |||||||||||
| Topological domain | 219 – 309 | 91 | Extracellular Potential | |||||||||||
| Transmembrane | 310 – 334 | 25 | Helical; Name=S6 of repeat I; Potential | |||||||||||
| Topological domain | 335 – 432 | 98 | Cytoplasmic Potential | |||||||||||
| Transmembrane | 433 – 451 | 19 | Helical; Name=S1 of repeat II; Potential | |||||||||||
| Topological domain | 452 – 466 | 15 | Extracellular Potential | |||||||||||
| Transmembrane | 467 – 486 | 20 | Helical; Name=S2 of repeat II; Potential | |||||||||||
| Topological domain | 487 – 494 | 8 | Cytoplasmic Potential | |||||||||||
| Transmembrane | 495 – 513 | 19 | Helical; Name=S3 of repeat II; Potential | |||||||||||
| Topological domain | 514 – 523 | 10 | Extracellular Potential | |||||||||||
| Transmembrane | 524 – 542 | 19 | Helical; Name=S4 of repeat II; Potential | |||||||||||
| Topological domain | 543 – 561 | 19 | Cytoplasmic Potential | |||||||||||
| Transmembrane | 562 – 581 | 20 | Helical; Name=S5 of repeat II; Potential | |||||||||||
| Topological domain | 582 – 636 | 55 | Extracellular Potential | |||||||||||
| Transmembrane | 637 – 661 | 25 | Helical; Name=S6 of repeat II; Potential | |||||||||||
| Topological domain | 662 – 799 | 138 | Cytoplasmic Potential | |||||||||||
| Transmembrane | 800 – 818 | 19 | Helical; Name=S1 of repeat III; Potential | |||||||||||
| Topological domain | 819 – 834 | 16 | Extracellular Potential | |||||||||||
| Transmembrane | 835 – 854 | 20 | Helical; Name=S2 of repeat III; Potential | |||||||||||
| Topological domain | 855 – 866 | 12 | Cytoplasmic Potential | |||||||||||
| Transmembrane | 867 – 885 | 19 | Helical; Name=S3 of repeat III; Potential | |||||||||||
| Topological domain | 886 – 892 | 7 | Extracellular Potential | |||||||||||
| Transmembrane | 893 – 911 | 19 | Helical; Name=S4 of repeat III; Potential | |||||||||||
| Topological domain | 912 – 930 | 19 | Cytoplasmic Potential | |||||||||||
| Transmembrane | 931 – 950 | 20 | Helical; Name=S5 of repeat III; Potential | |||||||||||
| Topological domain | 951 – 1040 | 90 | Extracellular Potential | |||||||||||
| Transmembrane | 1041 – 1065 | 25 | Helical; Name=S6 of repeat III; Potential | |||||||||||
| Topological domain | 1066 – 1118 | 53 | Cytoplasmic Potential | |||||||||||
| Transmembrane | 1119 – 1137 | 19 | Helical; Name=S1 of repeat IV; Potential | |||||||||||
| Topological domain | 1138 – 1152 | 15 | Extracellular Potential | |||||||||||
| Transmembrane | 1153 – 1172 | 20 | Helical; Name=S2 of repeat IV; Potential | |||||||||||
| Topological domain | 1173 – 1180 | 8 | Cytoplasmic Potential | |||||||||||
| Transmembrane | 1181 – 1199 | 19 | Helical; Name=S3 of repeat IV; Potential | |||||||||||
| Topological domain | 1200 – 1231 | 32 | Extracellular Potential | |||||||||||
| Transmembrane | 1232 – 1250 | 19 | Helical; Name=S4 of repeat IV; Potential | |||||||||||
| Topological domain | 1251 – 1269 | 19 | Cytoplasmic Potential | |||||||||||
| Transmembrane | 1270 – 1289 | 20 | Helical; Name=S5 of repeat IV; Potential | |||||||||||
| Topological domain | 1290 – 1356 | 67 | Extracellular Potential | |||||||||||
| Transmembrane | 1357 – 1381 | 25 | Helical; Name=S6 of repeat IV; Potential | |||||||||||
| Topological domain | 1382 – 1873 | 492 | Cytoplasmic Potential | |||||||||||
| Repeat | 38 – 337 | 300 | I | |||||||||||
| Repeat | 418 – 664 | 247 | II | |||||||||||
| Repeat | 786 – 1068 | 283 | III | |||||||||||
| Repeat | 1105 – 1384 | 280 | IV | |||||||||||
| Calcium binding | 1410 – 1421 | 12 | By similarity | |||||||||||
| Region | 357 – 374 | 18 | Binding to the beta subunit | |||||||||||
| Region | 988 – 1077 | 90 | Dihydropyridine binding | |||||||||||
| Region | 1337 – 1403 | 67 | Dihydropyridine binding | |||||||||||
| Region | 1349 – 1391 | 43 | Phenylalkylamine binding | |||||||||||
| Compositional bias | 562 – 568 | 7 | Poly-Leu | |||||||||||
Sites | ||||||||||||||
| Site | 292 | 1 | Calcium ion selectivity and permeability By similarity | |||||||||||
| Site | 614 | 1 | Calcium ion selectivity and permeability By similarity | |||||||||||
| Site | 1014 | 1 | Calcium ion selectivity and permeability By similarity | |||||||||||
| Site | 1323 | 1 | Calcium ion selectivity and permeability By similarity | |||||||||||
| Site | 1690 – 1691 | 2 | Cleavage Probable | |||||||||||
Amino acid modifications | ||||||||||||||
| Modified residue | 687 | 1 | Phosphoserine; by PKA Ref.7 | |||||||||||
| Modified residue | 1392 | 1 | Phosphoserine; by PKA Potential | |||||||||||
| Modified residue | 1617 | 1 | Phosphoserine; by PKA Ref.7 | |||||||||||
| Glycosylation | 79 | 1 | N-linked (GlcNAc...) Potential | |||||||||||
| Glycosylation | 257 | 1 | N-linked (GlcNAc...) Potential | |||||||||||
Natural variations | ||||||||||||||
| Natural variant | 165 | 1 | R → K. | |||||||||||
| Natural variant | 258 | 1 | G → D. | |||||||||||
| Natural variant | 1870 | 1 | P → L. | |||||||||||
Experimental info | ||||||||||||||
| Sequence conflict | 694 | 1 | T → R in AAA31159. Ref.2 | |||||||||||
| Sequence conflict | 1808 | 1 | T → M in AAA31159. Ref.2 | |||||||||||
| Sequence conflict | 1815 | 1 | A → V in AAA31159. Ref.2 | |||||||||||
| Sequence conflict | 1835 | 1 | A → E in AAA31159. Ref.2 | |||||||||||
Secondary structure | ||||||||||||||
Helix Strand Turn | ||||||||||||||
| Helix | 359 – 372 | 14 | ||||||||||||
| Helix | 672 – 677 | 6 | ||||||||||||
| Turn | 678 – 681 | 4 | ||||||||||||
Sequences
| ||||||||||||||||||
References
| [1] | "Primary structure of the receptor for calcium channel blockers from skeletal muscle." Tanabe T., Takeshima H., Mikami A., Flockerzi V., Takahashi H., Kangawa K., Kojima M., Matsuo H., Hirose T., Numa S. Nature 328:313-318(1987) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE. Tissue: Skeletal muscle. |
| [2] | "Sequence and expression of mRNAs encoding the alpha 1 and alpha 2 subunits of a DHP-sensitive calcium channel." Ellis S.B., Williams M.E., Ways N.R., Brenner R., Sharp A.H., Leung A.T., Campbell K.P., McKenna E., Koch W.J., Hui A., Schwartz A., Harpold M.M. Science 241:1661-1664(1988) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Skeletal muscle. |
| [3] | "Calcium channel beta-subunit binds to a conserved motif in the I-II cytoplasmic linker of the alpha 1-subunit." Pragnell M., de Waard M., Mori Y., Tanabe T., Snutch T.P., Campbell K.P. Nature 368:67-70(1994) [PubMed] [Europe PMC] [Abstract] Cited for: BETA-SUBUNIT BINDING DOMAIN. |
| [4] | "Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels." Striessnig J., Glossmann H., Catterall W.A. Proc. Natl. Acad. Sci. U.S.A. 87:9108-9112(1990) [PubMed] [Europe PMC] [Abstract] Cited for: PHENYLALKYLAMINE-BINDING SITE. |
| [5] | "Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine." Nakayama H., Taki M., Striessnig J., Glossmann H., Catterall W.A., Kanaoka Y. Proc. Natl. Acad. Sci. U.S.A. 88:9203-9207(1991) [PubMed] [Europe PMC] [Abstract] Cited for: DIHYDROPYRIDINE-BINDING SITE. |
| [6] | "Dihydropyridine receptor of L-type Ca2+ channels: identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the alpha 1 subunit." Striessnig J., Murphy B.J., Catterall W.A. Proc. Natl. Acad. Sci. U.S.A. 88:10769-10773(1991) [PubMed] [Europe PMC] [Abstract] Cited for: DIHYDROPYRIDINE-BINDING SITE. |
| [7] | "CAMP-dependent protein kinase rapidly phosphorylates serine-687 of the skeletal muscle receptor for calcium channel blockers." Roehrkasten A., Meyer H.E., Nastainczyk W., Sieber M., Hofmann F. J. Biol. Chem. 263:15325-15329(1988) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-687 AND SER-1617. |
| [8] | "Activation of purified calcium channels by stoichiometric protein phosphorylation." Nunoki K., Florio V., Catterall W.A. Proc. Natl. Acad. Sci. U.S.A. 86:6816-6820(1989) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION BY PKA. |
| [9] | "Activation and inhibition of skeletal RyR channels by a part of the skeletal DHPR II-III loop: effects of DHPR Ser687 and FKBP12." Dulhunty A.F., Laver D.R., Gallant E.M., Casarotto M.G., Pace S.M., Curtis S. Biophys. J. 77:189-203(1999) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH RYR1. |
| [10] | "A structural requirement for activation of skeletal ryanodine receptors by peptides of the dihydropyridine receptor II-III loop." Casarotto M.G., Gibson F., Pace S.M., Curtis S.M., Mulcair M., Dulhunty A.F. J. Biol. Chem. 275:11631-11637(2000) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 671-690. |
| [11] | "Structural analysis of the voltage-dependent calcium channel beta subunit functional core and its complex with the alpha1 interaction domain." Opatowsky Y., Chen C.-C., Campbell K.P., Hirsch J.A. Neuron 42:387-399(2004) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 34-415 IN COMPLEX WITH CACNB2. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | X05921 mRNA. Translation: CAA29355.1. M23919 mRNA. Translation: AAA31159.1. | ||||||||||||||||||
| PIR | A30063. | ||||||||||||||||||
| RefSeq | NP_001095190.1. NM_001101720.1. | ||||||||||||||||||
| UniGene | Ocu.1826. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| DisProt | DP00228. DP00440. | ||||||||||||||||||
| ProteinModelPortal | P07293. | ||||||||||||||||||
| SMR | P07293. Positions 1517-1543. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| MINT | MINT-8146707. | ||||||||||||||||||
| STRING | 9986.ENSOCUP00000003147. | ||||||||||||||||||
Protein family/group databases | |||||||||||||||||||
| TCDB | 1.A.1.11.2. voltage-gated ion channel (VIC) superfamily. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| GeneID | 100009585. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 779. | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| eggNOG | COG1226. | ||||||||||||||||||
| HOGENOM | HOG000231529. | ||||||||||||||||||
| HOVERGEN | HBG050763. | ||||||||||||||||||
| OrthoDB | EOG45755Q. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| Gene3D | 1.20.120.350. 4 hits. | ||||||||||||||||||
| InterPro | IPR005821. Ion_trans_dom. IPR027359. K_channel_four-helix_dom. IPR014873. VDCC_a1su_IQ. IPR005450. VDCC_L_a1ssu. IPR005446. VDCC_L_a1su. IPR002077. VDCCAlpha1. [Graphical view] | ||||||||||||||||||
| PANTHER | PTHR10037:SF105. PTHR10037:SF105. 1 hit. | ||||||||||||||||||
| Pfam | PF08763. Ca_chan_IQ. 1 hit. PF00520. Ion_trans. 4 hits. [Graphical view] | ||||||||||||||||||
| PRINTS | PR00167. CACHANNEL. PR01630. LVDCCALPHA1. PR01634. LVDCCALPHA1S. | ||||||||||||||||||
| SMART | SM01062. Ca_chan_IQ. 1 hit. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| ChEMBL | CHEMBL4169. | ||||||||||||||||||
| EvolutionaryTrace | P07293. | ||||||||||||||||||
Entry information
| Entry name | CAC1S_RABIT | ||||||||
| Accession | Primary (citable) accession number: P07293 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| Recent format changes Overview of recent format changes |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
